BOCA RATON, Fla., March 18 /PRNewswire-FirstCall/ -- MedeFile International, Inc. (OTC Bulletin Board: MDFI), a leader in portable electronic medical records management, announced today the addition of internationally-renowned biotechnology veteran Dr. Gurinder Shahi, M.D., Ph.D., to its Advisory Board.
The co-founder and CMO of Rhapsody Holdings, LLC, Dr. Gurinder Shahi has served as an advisor and consultant to the World Bank and the World Health Organization, as well as governments, corporations and foundations on such progressive health issues as health systems, life science technology innovation/ commercialization management and biotech industry development.
A widely published author, fierce advocate and practicing physician specializing in molecular biology and international health policy, Dr. Shahi said of his appointment, "I am very pleased to be serving on MedeFile's Advisory Board. In the US, MedeFile's innovations in PHR represent the kind of technological advances in healthcare that I have spent my career advocating for internationally."
Working at the central point of healthcare and technology, Dr. Shahi, a trailblazer in the convergence of healthcare and technology, pointed out, "Time and time again I've seen the importance of supporting advances in digital medical records in healthcare." Having spent his career facilitating and promoting innovation, public-private partnership and interdisciplinary collaboration in health care, life sciences and biotechnology, Dr. Shahi added, "It is in this vein that I look forward to helping MedeFile bring its innovations in PHR to the rest of the world."
Dr. Shahi's book, "BioBusiness in Asia: How Asia Can Capitalize on the Life Science Revolution," has been used as a blueprint for biotechnology industry development in several countries around the world. Gurinder has also been actively involved in providing strategic and management input to a range of start-up enterprises and in helping a growing number of US, European and Australian enterprises establish strategic alliances and build their operations in Asia.
With degrees from Harvard and the National University of Singapore, Dr. Shahi served as the Director of Operations and Program Development of the International Vaccine Institute, founding Executive Director and Coordinator of The Asia-Pacific International Molecular Biology Network and founding Director of the Global BioBusiness Initiative.
The author of over 60 published articles in the field, Dr. Shahi is a frequent presenter and speaker at international healthcare conferences worldwide and is presently working on several new initiatives dedicated to the development of technology solutions for health and wellness management.
Milton Hauser, CEO of MedeFile, said, "The addition of Dr. Shahi to our advisory board is a giant step in our ongoing commitment to bringing the innovations of Personal Health Records to the world stage. Gurinder's efforts in helping to bring international health policy into the 21st Century are an inspiration and a beacon to all of us working in healthcare today."
About MedeFile International, Inc.
Headquartered in South Florida, MedeFile has a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is the MedeFile system, a highly secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week. For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com
Safe Harbor Statement Under the Private Securities Litigation Act of 1995
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.
Contact: +1-561-912-3393 ext. 155, Investor@medefile.com
SOURCE MedeFile International, Inc.Back to top
|SOURCE MedeFile International, Inc.|
Copyright©2010 PR Newswire.
All rights reserved